- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02086201
Comparing Engage to PST for Late Life Depression (Engage)
Stepped, Reward-exposure Based Therapy vs. PST in Late Life Depression
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Policy reports document that evidence-based psychotherapies are rarely employed and sustained in the community. Several causes of this science to service gap have been identified. One cause, specific to behavioral interventions, is the complexity of interventions and the competencies community clinicians must acquire and sustain over time in order to deliver them. A realistic solution is to streamline behavioral interventions and tailor them to the settings and therapist skill level available in the community. In response to this need, we have developed Engage, which: 1) is streamlined on the basis of concepts and findings on the neurobiology of depression; 2) consists of psychotherapeutic and ecosystem management components of known efficacy; 3) has distilled and simplified these components so as they can be accessible to most depressed older patients and taught to larger numbers of clinicians than available therapies, e.g., Problem Solving Therapy (PST); and 4) is personalized through a structured stepped approach focusing on "reward exposure". Problem Solving Therapy is an evidenced-based intervention shown to be effective in treating late-life depression.
Three hundred (150 per site) patient participants will be randomly assigned to receive 9 sessions of either Engage or PST. Forty-two clinician participants will be randomly assigned to receive training and certification in either Engage or PST. Once certified, clinicians will be assigned a patient participant and administer their assigned intervention.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
New York
-
White Plains, New York, Vereinigte Staaten, 10605
- Weill Medical College of Cornell University
-
-
Washington
-
Seattle, Washington, Vereinigte Staaten, 98195
- University of Washington Department of Psychiatry and Behavioral Sciences
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria (Patient participants):
- Age ≥ 60 years
- unipolar, non-psychotic major depression (by SCID, DSM-IV)
- MADRS ≥ 20
- MMSE ≥ 24
- off antidepressants or have been on a stable dose of an antidepressant for 12 weeks and do not intend to change the dose in the next 10 weeks
- English speaking
- capacity to provide written consent
Exclusion Criteria (Patient participants):
- Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder
- Newly started use of psychotropic drugs (<12wks) or cholinesterase inhibitors other than mild doses of benzodiazepines
- Current active suicidal intent/plan
- Current substance abuse
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Aktiver Komparator: Problem Solving Therapy
Problem solving therapy is an evidence based psychotherapy for depression, with 30 years of research supporting its efficacy.
PST focuses on the patients themselves and helps them develop skills in identifying, prioritizing, and solving problems, and thereby creates a sense of empowerment.
|
PST is a behavioral intervention for depression that is delivered by trained therapists over a 9 week period.
It consists of a process to help patients understand and then solve the problems in their lives they feel is contributing to their depression.
|
Experimental: Engage
Engage utilizes reward exposure consisting of the reintroduction of activities that patients once found rewarding and enjoyed, but have abandoned after they developed depression.
Engage uses basic problem solving through which patients learn how to form "action plans" for pursuing rewarding activities of their choice.
|
Engage is a weekly behavioral intervention that is delivered over a 9 week period of time by trained therapists.
The focus of Engage is to help patient reconnect with activities that they have lost interest in pursuing due to depression.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Depression
Zeitfenster: Measured at pretreatment and weeks 2,4,6,8,9,26 and 36
|
Depression will be assessed using the Hamilton Depression Rating Scale, a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
|
Measured at pretreatment and weeks 2,4,6,8,9,26 and 36
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: George Alexopoulos, M.D., Weill Medical College of Cornell University
- Hauptermittler: Patricia Arean, PhD, UW
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- STUDY00001739
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Schwere Depression
-
Yonsei UniversityAbgeschlossen
-
University of British ColumbiaMichael Smith Foundation for Health ResearchRekrutierung
-
PfizerAbgeschlossen
-
Ruijin HospitalBeendetBehandlungsresistente Major Depression DisorderChina
-
The Royal Ottawa Mental Health CentreRekrutierung
-
Assistance Publique Hopitaux De MarseilleAbgeschlossen
-
AccexibleRekrutierungMajor Depression (MDD)Spanien
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Noch keine Rekrutierung
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RekrutierungUntersuchung von magensaftresistenten Ammoxetinhydrochlorid-Tabletten bei Patienten mit DepressionenMajor Depression (MDD)China
-
Seasons Biotechnology (Taizhou) Co., Ltd.AbgeschlossenMajor Depression (MDD)Indien
Klinische Studien zur Problem Solving Therapy
-
Hopital MontfortAbgeschlossenBetonen | Burnout, Profi | AusbrennenKanada
-
Paragon Vision SciencesAbgeschlossenKurzsichtigkeitVereinigte Staaten
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)Aktiv, nicht rekrutierendStreicheln | Aphasie | Aphasie nicht fließendVereinigte Staaten
-
Children's Hospital Medical Center, CincinnatiRekrutierungIntraventrikuläre BlutungVereinigte Staaten
-
Columbia UniversityBeendet
-
University Hospital, GenevaAbgeschlossenAlpträume, REM-SchlaftypSchweiz
-
Chinese University of Hong KongRekrutierung
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RekrutierungLatente TuberkuloseVereinigte Staaten
-
University of Applied Sciences and Arts of Southern...Vrije Universiteit Brussel; Universiteit Antwerpen; THIM - die internationale...Abgeschlossen
-
University of South FloridaUnited States Department of DefenseAbgeschlossenPTBS | Psychologisches TraumaVereinigte Staaten